Welcome to Belrose Pharma official website
Contact : 609.917.3013



In-Pharma: Belrose Buys Enzon’s Pegylation Platform and Drug Candidates

Drugmakers have been slow to adopt releasable PEGylation according to Belrose Pharma, which plans to use a tech it has bought from Enzon to expand… Read More ›

Belrose Pharma Acquires Enzon’s Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies

New Specialty Pharmaceutical Company to Use Chemical Polyethylene Glycol Attachment Technique to Create Safer, Longer-Lasting, More Effective Drug Therapies Princeton, NJ, June 19, 2013 –… Read More ›

Belrose Pharma Launched to Develop Innovative Therapeutics for Diseases with High Unmet Medical Needs

New Specialty Pharmaceutical Company to Drive Development in Sustained Drug Release Products Princeton, NJ, June 18, 2013 -- Belrose Pharma Inc., a new specialty pharmaceutical… Read More ›